首页> 外文期刊>Pediatric radiology >Practical administration of intravenous contrast media in children: screening, prophylaxis, administration and treatment of adverse reactions
【24h】

Practical administration of intravenous contrast media in children: screening, prophylaxis, administration and treatment of adverse reactions

机译:儿童静脉内造影剂的实际施用:筛选,预防,给药和治疗不良反应

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Administration of intravenous contrast media to children is a routine practice at many clinical imaging centers, that can involve special considerations. In this paper, we provide practical information to facilitate optimal performance and oversight of this task. We provide targeted screening questions that can help to identify high-risk pediatric patients for both iodine-based and gadolinium-based intravenous contrast media administration. These include children at risk for allergic-like reactions, thyroid dysfunction, contrast-induced nephropathy, and nephrogenic systemic fibrosis. We make recommendations for addressing yes responses to screening questions using risk stratification schema that are specific to children. We also present criteria for selecting children for premedication prior to intravenous contrast administration, and suggest pediatric regimens. Additionally, we discuss practical nuances of intravenous contrast media administration to children and provide a quick-reference table of appropriate treatments with pediatric dosages for adverse contrast reactions.
机译:静脉注射造影剂给儿童的施用是许多临床成像中心的常规实践,可以涉及特殊考虑因素。在本文中,我们提供了实用信息,以便于最佳性能和监督此任务。我们提供有针对性的筛查问题,可以帮助识别高危小儿患者,用于碘基和基于钆的静脉内造影剂介质给药。这些包括有过敏反应,甲状腺功能障碍,对比引起的肾病和肾病系统纤维化的风险的儿童。我们提出建议,以解决是使用特定于儿童的风险分层模式对筛选问题的答案。在静脉内对比度给药之前,我们还呈现了选择儿童的儿童的标准,并提示小儿方案。此外,我们讨论静脉内造影剂给予儿童的实际细微差别,并提供具有儿科剂量的适当治疗表,用于不良对比反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号